- Home
- DNTH vs ENPH Comparison
DNTH vs ENPH Comparison
Compare DNTH & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | ENPH |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.5B |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | DNTH | ENPH |
|---|---|---|
| Price | $86.57 | $64.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 23 |
| Target Price | ★ $121.00 | $41.30 |
| AVG Volume (30 Days) | 422.6K | ★ 8.4M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.00 |
| EPS | N/A | ★ N/A |
| Revenue | $2,036,000.00 | ★ $1,472,985,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.48 | $9.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.72 |
| 52 Week Low | $16.77 | $25.78 |
| 52 Week High | $96.50 | $63.28 |
Technical Indicators
Market Signals| Indicator | DNTH | ENPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 77.68 |
| Support Level | $82.00 | $32.08 |
| Resistance Level | $90.23 | N/A |
| Average True Range (ATR) | 4.58 | 4.93 |
| MACD | -0.20 | 2.73 |
| Stochastic Oscillator | 52.27 | 97.48 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About ENPH Enphase Energy Inc.
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.